Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas.
about
Fertility preservation for boys and adolescents facing sterilizing medical therapyFDA-approved medications that impair human spermatogenesisHigh risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood.Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.Sperm cryopreservation practices among adolescent cancer patients at risk for infertility.Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas.Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort studyClinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.Inhibition of spermatogonial differentiation by testosterone.Preservation of fertility in children treated for cancer.Fertility following treatment of high-grade malignant bone and soft tissue tumors in young adults.Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.Endocrine complications in children and adolescents with cancer.Cryopreservation of testis tissues and in vitro spermatogenesisReproductive outcomes for survivors of childhood cancer.The biology of infertility: research advances and clinical challenges.Effects of chemotherapy and radiotherapy on spermatogenesis in humans.Male gonadal toxicity.Biomarkers of chemotherapy-induced testicular damage.Irinotecan metabolite SN38 results in germ cell loss in the testis but not in the ovary of prepubertal mice.An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety.The impact of lymphoma and treatment on male fertility.Cutting-edge issues in autoimmune orchitis.Oncofertility and the male cancer patient.Fertility preservation in patients receiving cyclophosphamide therapy for renal disease.State of the art in the treatment of systemic vasculitides.Adverse effects of common medications on male fertility.Advances in cryopreservation of spermatogonial stem cells and restoration of male fertility.Antimetastatic effects of licochalcone B on human bladder carcinoma T24 by inhibition of matrix metalloproteinases-9 and NF-кB activity.Male reproductive health after childhood cancer.Gene expression profiles of mouse spermatogenesis during recovery from irradiationIsoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide.Gonadotropin-releasing hormone antagonist (Cetrorelix) therapy fails to protect nonhuman primates (Macaca arctoides) from radiation-induced spermatogenic failure.Immunosuppressants and Male Reproduction.The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.Cancer treatment in childhood and testicular function: the role of the somatic environment.Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.Testicular sperm extraction and ICSI in patients with post-chemotherapy non-obstructive azoospermia.
P2860
Q26773927-773CA0EE-1233-43E4-9F8B-9E473EB286E0Q28068325-FF69784A-5A86-4246-88B7-74A1ABF47C5EQ31911684-D784C469-31EE-472B-820F-1F213D585CC7Q33516921-E1B4676F-3C02-4813-93F1-7208B9A626ECQ33571864-FCAFFAEF-3E05-4DE8-951A-11BEFC251BACQ33572503-1AC76BD0-ADA9-4D72-A928-74DC390CEC29Q34190100-1B71D88F-CFA6-418E-97E5-C3CB5798EAD4Q34287195-7D3AD3D6-BAF4-4682-8EC9-81501A2FC08AQ34592357-9114F9D0-1F04-44B2-9ACB-7ECD82B803DBQ35021459-11A11AEF-DC3B-460A-B334-E8A5A3E7084CQ35084440-28742122-2522-44F4-A713-0829FE0DDED4Q35135618-7F10D5CB-2AAC-4E13-90BC-E433F3820C45Q35179978-A3DB2A22-BF9C-4E9C-B00A-8EF56C4C6DDAQ36222944-1970EAB2-78CA-4B07-819D-081D169BEE77Q36362629-A97F3FB8-41E4-48A1-8732-D29BBEB163AFQ36391756-CCC3A5F8-F576-4CE5-822C-6BCCEC2A20CBQ36509306-11EDEA3A-9CD4-4CA7-8118-467596A3D90AQ37206451-772BB050-39DF-4152-B149-23A43F026CBFQ37305907-81AB6A0F-0823-4381-8D3F-7C59285C9C89Q37332885-055883D9-3711-4871-BC99-935A5F7C40D3Q37342459-0F8B918B-F123-48DB-A9A8-C94D74F8A35CQ37400331-B74A66B1-5D86-4B3F-A166-2C4F2E9195E7Q37479062-CD01B5D8-7D6F-4D5A-B44E-5DA1BB07CB80Q37810970-C0A81E5D-6878-4E21-9FE5-FE9928163DD9Q37917646-3BBBE7D7-539E-43AE-90B3-D4EE64A7DF6BQ38004994-D9826BAD-64BB-4141-8C2C-DEDD1D6009F7Q38246219-658B77AF-E3F7-4337-A0CC-25A236E2C472Q38263514-835646BB-74C5-46F3-A731-9A7A83E6CAA6Q38534996-364DF395-4D53-46AB-A3F1-D68FBE9454D1Q38661628-17066B32-FC14-429A-96F3-ACE96CC31A25Q38968280-AF1849D7-5AE2-44F2-96DC-C1667B8BC428Q42171212-8290B706-394F-41AB-B174-4D2F0BA0942FQ42678314-6B5D7822-6F34-46BD-8EB4-92106E5EE2F2Q43567481-0693FFDF-186F-4C7E-BAE3-0C4D55C0B629Q45267416-51ACA401-3DD2-4ED8-9F71-1E468CE51537Q46236864-7E4DD9C9-776D-4BF4-89A7-B51297782140Q46790290-D8267110-23FB-4298-8575-F217AC7E41FEQ47722771-9673066F-8147-4C78-AEB0-F34C572C5847Q48536321-C110617A-7155-4212-A4EA-D733E2D39060Q48603798-F1B57F38-BEAE-45FE-B4AE-697213FDF865
P2860
Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@en
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@nl
type
label
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@en
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@nl
prefLabel
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@en
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@nl
P2093
P1433
P1476
Impact of cyclophosphamide on ...... wing and soft tissue sarcomas.
@en
P2093
Lipshultz LI
Meistrich ML
da Cunha MF
P304
P356
10.1002/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X
P407
P577
1992-12-01T00:00:00Z